Matches in Nanopublications for { ?s ?p "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP789293.RAdsBVfhA6XtRROLiQd6oj9P0BvFyECJLDGoQLp8RFS3Q130_assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789293.RAdsBVfhA6XtRROLiQd6oj9P0BvFyECJLDGoQLp8RFS3Q130_provenance.
- NP789298.RAqLhivW7L1yLibzP011XVD5iwsXer6y_gZQZt28DqfJ8130_assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789298.RAqLhivW7L1yLibzP011XVD5iwsXer6y_gZQZt28DqfJ8130_provenance.
- NP789294.RALaBbF9HMqSCBu-2dc8Vo_pRGuyn8DW6Z3MME-Oo_MAo130_assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789294.RALaBbF9HMqSCBu-2dc8Vo_pRGuyn8DW6Z3MME-Oo_MAo130_provenance.
- NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_assertion description "[TOP2A has aroused particular interest as over-expression of its protein has been shown to correlate, both with amplification of HER2/neu, and with response to anthracycline-based chemotherapeutic agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789297.RAyz8hJyYLWyIh-7oxgx9fRr4gQ5U--UKAiI2lVn6iPRk130_provenance.